Comparison of ramosetron with ondansetron for the prophylaxis of PONV after craniotomy.
Phase of Trial: Phase II
Latest Information Update: 31 May 2017
At a glance
- Drugs Ondansetron; Ramosetron
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 25 Mar 2013 Status changed from not yet recruiting to completed as reported by Korean Clinical Trials Register record.
- 18 Feb 2012 New trial record